Atria Wealth Solutions’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-14,308
Closed -$560K – 1936
2023
Q3
$560K Sell
14,308
-4,263
-23% -$170K 0.01% 1080
2023
Q2
$755K Sell
18,571
-26,113
-58% -$1.07M 0.01% 974
2023
Q1
$1.87M Sell
44,684
-5,099
-10% -$215K 0.03% 567
2022
Q4
$2.17M Sell
49,783
-1,777
-3% -$75.5K 0.03% 485
2022
Q3
$2M Buy
+51,560
New +$2.2M 0.03% 480
2022
Q2
– Sell
-12,740
Closed -$580K – 1653
2022
Q1
$580K Buy
+12,740
New +$565K 0.01% 982

Other funds holding BME

Atria Wealth Solutions's BME Position: Q4 2023 in Review

Atria Wealth Solutions sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 14,308 shares — an estimated $560K sold.

Atria Wealth Solutions first reported a position in BME in Q1 2022 and held it in 6 quarters. The position peaked at $2.17M in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Atria Wealth Solutions reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 14,308 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $560K.
  • Atria Wealth Solutions first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 6 quarters.
  • Atria Wealth Solutions's BlackRock Health Sciences Trust position peaked at $2.17M in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Atria Wealth Solutions's 13F filing for Q4 2023, filed 2 Feb 2024.